Anupam Rasayan India Limited — Updates, 23-05-2025: Press Release

Anupam Rasayan reported Q4FY25 revenue up 22% YoY at ₹506 Cr, boosted by pharma, polymer, and Tanfac segments, with a strong 30% EBITDA margin and PAT rising 56% YoY. FY25 revenue fell 4% YoY to ₹1,448 Cr, while EBITDA margin remained steady at 28% and PAT was slightly down. H2FY25 showed signs of recovery after a soft first half, with management optimistic about regaining historic growth momentum.